RKLY - Rockley Photonics signs supply agreement for non-invasive biosensing wristband

• Rockley Photonics ( NYSE: RKLY ) signed a supply agreemen t outlining the customer's initial purchase commitment for 2023 and received the first commercial purchase order for its non-invasive biomarker sensing wristbands from a global healthcare technology provider.
• The Bioptx Baseline devices included in this order will employ Rockley’s biosensing technology, a complete end-to-end solution.
• The initial units are expected to ship in Q4 2022, which could put Rockley's ground-breaking biosensing technology on the wrists of end-users by 2022 end.
• To support the demand, the company has established the manufacturing partnerships to provide high-volume production, which is planned for 2023.

For further details see: